These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36394909)

  • 21. Mechanism of the activation step of the aminoacylation reaction: a significant difference between class I and class II synthetases.
    Banik SD; Nandi N
    J Biomol Struct Dyn; 2012; 30(6):701-15. PubMed ID: 22731388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cys-tRNA(Pro) editing by Haemophilus influenzae YbaK via a novel synthetase.YbaK.tRNA ternary complex.
    An S; Musier-Forsyth K
    J Biol Chem; 2005 Oct; 280(41):34465-72. PubMed ID: 16087664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and functional analysis of the anti-malarial drug target prolyl-tRNA synthetase.
    Jain V; Kikuchi H; Oshima Y; Sharma A; Yogavel M
    J Struct Funct Genomics; 2014 Dec; 15(4):181-90. PubMed ID: 25047712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The structural basis of cysteine aminoacylation of tRNAPro by prolyl-tRNA synthetases.
    Kamtekar S; Kennedy WD; Wang J; Stathopoulos C; Söll D; Steitz TA
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1673-8. PubMed ID: 12578991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional association between three archaeal aminoacyl-tRNA synthetases.
    Praetorius-Ibba M; Hausmann CD; Paras M; Rogers TE; Ibba M
    J Biol Chem; 2007 Feb; 282(6):3680-7. PubMed ID: 17158871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminoacyl-tRNA synthetase (AARS) as an attractive drug target in neglected tropical trypanosomatid diseases-Leishmaniasis, Human African Trypanosomiasis and Chagas disease.
    Kushwaha V; Capalash N
    Mol Biochem Parasitol; 2022 Sep; 251():111510. PubMed ID: 35988745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance.
    Tye MA; Payne NC; Johansson C; Singh K; Santos SA; Fagbami L; Pant A; Sylvester K; Luth MR; Marques S; Whitman M; Mota MM; Winzeler EA; Lukens AK; Derbyshire ER; Oppermann U; Wirth DF; Mazitschek R
    Nat Commun; 2022 Aug; 13(1):4976. PubMed ID: 36008486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of Prolyl-tRNA Synthetase-Halofuginone Complex Provides Basis for Development of Drugs against Malaria and Toxoplasmosis.
    Jain V; Yogavel M; Oshima Y; Kikuchi H; Touquet B; Hakimi MA; Sharma A
    Structure; 2015 May; 23(5):819-829. PubMed ID: 25817387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [tRNA-dependent editing of errors by prolyl-tRNA synthetase from bacteria Enterococcus faecalis].
    Boiarshin KS; Kriklivyĭ IA; Tukalo MA
    Ukr Biokhim Zh (1999); 2008; 80(6):52-9. PubMed ID: 19351057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asymmetric behavior of archaeal prolyl-tRNA synthetase.
    Ambrogelly A; Kamtekar S; Stathopoulos C; Kennedy D; Söll D
    FEBS Lett; 2005 Nov; 579(27):6017-22. PubMed ID: 16226256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of aminoacyl-tRNA synthetases in infectious diseases and targets for therapeutic development.
    Dewan V; Reader J; Forsyth KM
    Top Curr Chem; 2014; 344():293-329. PubMed ID: 23666077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A dual-specificity aminoacyl-tRNA synthetase in the deep-rooted eukaryote Giardia lamblia.
    Bunjun S; Stathopoulos C; Graham D; Min B; Kitabatake M; Wang AL; Wang CC; Vivarès CP; Weiss LM; Söll D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(24):12997-3002. PubMed ID: 11078517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoacyl-tRNA synthetase inhibitors as potent antibacterials.
    Lv PC; Zhu HL
    Curr Med Chem; 2012; 19(21):3550-63. PubMed ID: 22680640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and characterization of a novel class of pyrazolopyrimidinedione tRNA synthesis inhibitors.
    Montgomery JI; Smith JF; Tomaras AP; Zaniewski R; McPherson CJ; McAllister LA; Hartman-Neumann S; Arcari JT; Lescoe M; Gutierrez J; Yuan Y; Limberakis C; Miller AA
    J Antibiot (Tokyo); 2015 Jun; 68(6):361-7. PubMed ID: 25464974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An isolated class II aminoacyl-tRNA synthetase insertion domain is functional in amino acid editing.
    Wong FC; Beuning PJ; Silvers C; Musier-Forsyth K
    J Biol Chem; 2003 Dec; 278(52):52857-64. PubMed ID: 14530268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of adenosine triphosphate and magnesium chloride on affinity elution of aminoacyl-transfer ribonucleic acid synthetases from phosphocellulose with transfer ribonucleic acids.
    Yamada H
    J Biochem; 1978 Jun; 83(6):1577-81. PubMed ID: 353039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. tRNA(Pro) anticodon recognition by Thermus thermophilus prolyl-tRNA synthetase.
    Cusack S; Yaremchuk A; Krikliviy I; Tukalo M
    Structure; 1998 Jan; 6(1):101-8. PubMed ID: 9493271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding species-specific differences in substrate recognition by Escherichia coli and human prolyl-tRNA synthetases.
    Musier-Forsyth K; Stehlin C; Burke B; Liu H
    Nucleic Acids Symp Ser; 1997; (36):5-7. PubMed ID: 9478190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase.
    Hewitt SN; Dranow DM; Horst BG; Abendroth JA; Forte B; Hallyburton I; Jansen C; Baragaña B; Choi R; Rivas KL; Hulverson MA; Dumais M; Edwards TE; Lorimer DD; Fairlamb AH; Gray DW; Read KD; Lehane AM; Kirk K; Myler PJ; Wernimont A; Walpole C; Stacy R; Barrett LK; Gilbert IH; Van Voorhis WC
    ACS Infect Dis; 2017 Jan; 3(1):34-44. PubMed ID: 27798837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-transfer editing by class II prolyl-tRNA synthetase: role of aminoacylation active site in "selective release" of noncognate amino acids.
    Hati S; Ziervogel B; Sternjohn J; Wong FC; Nagan MC; Rosen AE; Siliciano PG; Chihade JW; Musier-Forsyth K
    J Biol Chem; 2006 Sep; 281(38):27862-72. PubMed ID: 16864571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.